Jeff Aronin serves as the chairman and CEO of Paragon Biosciences Company. The organization focuses on the development of medical treatment for individuals with rare diseases that have few or no treatment available. He is an alumnus of the Northern Illinois University from where he earned his Bachelor’s Degree besides attending the DePaul University where he received his MBA. After his education, Jeff Aronin served in the healthcare sector before venturing into his own business by establishing the Ovation Pharmaceuticals LLC in 2000 where he became its CEO.
Jeff Aronin’s Unique Medical Approach
Jeff Aronin’s main agenda in the establishment the Ovation Company was explicitly to pull resources together by involving top talent to come up with the unmet needs in the health industry. As a result, the uniqueness of his medical approach differentiated Ovation Pharmaceuticals from the other pharmacies as his primary concern was addressing the neglected group of patients with rare conditions. Besides, the ovation pharmaceuticals would later be sold at a price of $900 million in 2009 to a healthcare company from Denmark that was known as “Lundbeck”, where Jeff Aronin was maintained as its CEO.
About the Paragon Biosciences
Apart from the innovation and development of new medicine, Paragon Biosciences’ core business is to work with other health companies to formulate new drugs. So far, the company has been successful in developing new types of medication where it currently has a record of producing 13 approved drugs by the Food and Drug Administration body in the United States. What’ more, Jeff Aronin directs the company to follow a three-step master plan to develop the drugs which include identification, building, and production of the medication.
Furthermore, as a company in the business of networking with other health organizations, Paragon has helped other companies such as Harmony Biosciences and Castle Creek Pharmaceuticals to develop drugs. Also, an example of a rare disease that a company like Castle Creek focuses on includes the Epidermolysis Bulosa Simplex, which is a form of a rare dermatology ailment. Similarly, Harmony Biosciences concentrates on the rare condition of the central nervous system drugs where the disorders in this category are associated with illnesses such as Cataplexy and Narcolepsy.